Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIGKIS: Continuous vs Single-shot Interscalene Block in Shoulder Surgery
NCT04394130Completed
- Start
- May 2020
- Primary completion
- Aug 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms). Primary endpoint: Total i.v. morphine consumption at 24 hours postoperatively. Started May 2020; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04394130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394130.